PENYAKIT KOMORBID SEBAGAI FAKTOR RISIKO MORTALITAS PASIEN COVID-19
DOI:
https://doi.org/10.29303/jk.v11i3.4714Keywords:
COVID-19, Penyakit Komorbid, MortalitasAbstract
Penyakit Coronavirus 2019 (COVID-19) adalah penyakit saluran pernafasan menular yang disebabkan oleh Coronavirus jenis baru yang belum pernah diidentifikasi sebelumnya yaitu SARS-CoV-2. Tingginya kasus kematian pada pasien COVID-19 dikaitkan dengan adanya penyakit penyerta seperti hipertensi, diabetes melitus, penyakit kardiovaskular, penyakit paru obstruktif kronis, penyakit ginjal, kanker dan penyakit hati. Mekanisme patofisiologi komorbid dalam memperburuk gejala serta meningkatkan risiko mortalitas pada pasien COVID-19 sangat kompleks dan beragam. Pada penderita hipertensi, penyakit paru obstruktif kronis, dan penyakit ginjal terjadi peningkatan ekspresi reseptor ACE-2 menyebabkan sangat rentan terinfeksi COVID-19. Penurunan dan melemahnya sistem imun tubuh memainkan peran penting dalam perburukan gejala penyakit COVID-19 pada pasien kanker, penyakit hati dan penyakit kardiovaskular. Pada pasien diabetes, gangguan fungsi sel T dan peningkatan kadar interleukin-6 (IL-6) berperan dalam meningkatnya derajat penyakit COVID-19. Sedangkan pada pasien asma, ikatan silang IgE serta menurunnya produksi interferon menyebabkan pasien asma lebih rentan terinfeksi virus dan dapat memperburuk gejala serta eksaserbasi asma.Downloads
Published
2022-09-30
Issue
Section
Articles
License
Authors who publish with Unram Medical Journal, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC-BY License). This license allows authors to use all articles, data sets, graphics, and appendices in data mining applications, search engines, websites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in University of Mataram's Journal of Medicine.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- This journal is open access journal which means that all content is freely available without charge to users or / institution. Users are allowed to read, download, copy, distribute, print, search, or link to full text articles in this journal without asking prior permission from the publisher or author.